Veronika Nindl and her colleagues have revealed that IFN-γ is a key effector cytokine that triggers the inflammatory process and that the combination of IFN-γ and IL-17A is necessary for the transition from autoimmune myocarditis to DCM [100]. This evidence concerns the gene IL17A and familial dilated cardiomyopathy.